It contains 2 hormones: a progestin and an estrogen. Besides preventing pregnancy, birth control pills may make your periods more regular, decrease blood loss and painful periods, decrease your risk of ovarian cysts, and also treat acne. It is a birth control pill that contains two types of hormones, ethinyl estradiol and norgestimate, and when taken properly, prevents pregnancy. It works by stopping a woman's egg from fully developing each month. The egg can no longer accept a sperm and fertilization (pregnancy) is prevented. Description: Blue, Round Tablets [Days 15-21] Strength: 0.25 mg/0.035 mg Contains: Norgestimate and Ethinyl Estradiol Norgestimate/ethinyl estradiol is a combination birth control pill (oral contraceptive) used to prevent pregnancy in women. Norgestimate/ethinyl estradiol contains 2 types of hormones. The primary use of ethinyl estradiol norgestimate is to prevent pregnancy. The standard dose is one tablet daily for 21 days, followed by seven days of placebo pills, during which withdrawal bleeding occurs. The safety of Norgestimate and Ethinyl Estradiol Tablets USP (0.25 mg/0.035 mg) was evaluated in 1,647 healthy women of child-bearing potential who participated in 3 clinical trials and received at least 1 dose of Norgestimate and Ethinyl Estradiol Tablets USP (0.25 mg/0.035 mg) for contraception. What is this medication? NORGESTIMATE; ETHINYL ESTRADIOL (nor JES ti mate; ETH in il es tra DYE ole) prevents ovulation and pregnancy. It may also be used to treat acne. It belongs to a group of medications called oral contraceptives. It is a combination of the hormones estrogen and progestin. Ethinyl estradiol and norgestimate: side effects, dosage, interactions, FAQs, reviews. Used for: abnormal uterine bleeding, acne, birth control, endometriosis, and more. Ethinyl estradiol and norgestimate oral contraceptives will work only as long as they are taken regularly. Continue to take them as directed even if you are spotting or bleeding, have an upset stomach, or do not think that you are likely to become pregnant. Norgestimate was approved in combination with estradiol for use in menopausal hormone therapy in 1999 in the United States, and a generic version of this preparation became available in this country in 2005.